Long-term clinical outcome of patients with diabetes proposed for coronary revascularisation

Netherlands Journal of Medicine

Volumn 64, Issue 8, 2006, Pages 296-301

  Timmer, J R ^a   Breeman, A ^a   Ottervanger, J P ^a   de Kluiver, E P ^a   Boonstra, P W ^b   Zijlstra, F ^b  

^a Isala Klinieken ^*  (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

CABG; Diabetes; Revascularisation

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART MUSCLE REVASCULARIZATION; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEX DIFFERENCE; STATISTICAL SIGNIFICANCE; SURVIVAL; TREATMENT OUTCOME; TREATMENT RESPONSE;

AGED; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL REVASCULARIZATION; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 33749068713     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Barsness GW, Peterson ED, Ohman EM, et al. Relationship between diabetes and long-term survival after coronary bypass and angioplasty. Circulation 1997;96:2551-6.
2. Weintraub WS, Stein B, Kosinski A, et al. Outcome of coronary bypass surgery vs coronary angioplasty in diabetic patients with multivessel coronary artery disease. J Am Coll Cardiol 1998;31:10-9.
3. The BARI Investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 2000;35:1122-9.
4. Kurbaan AS, Bowker TJ, Ilsley CD, Sigwart U, Rickards AF, on behalf of the CABRI Investigators. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. (Coronary Angioplasty vs Bypass Revascularization Investigation). Am J Cardiol 2001;87:947-50.
5. King SB III, Kosinski AS, Guyton RA, Lembo NJ, Weintraub WS. Eight-year mortality in the Emory Angioplasty vs Surgery Trial (EAST). J Am Coll Cardiol 2000;35:1116-21.
6. Detre KM, Guo P, Holubkov R, et al. Coronary revascularization in diabetic patients: a comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1999;99:633-40.
7. Rigter H, Meijler AP, McDonnell J, Scholma JK, Bernstein SJ. Indications for coronary revascularisation: a Dutch perspective. Heart 1997;77:211-8.
8. Meijler AP, Rigter H, Bernstein SJ, et al. The appropriateness of intention to treat decisions for invasive therapy in coronary artery disease in The Netherlands. Heart 1997;77:219-24.
9. Winocour PD. Platelet abnormalities in diabetes. Diabetes 1992;41 (suppl 2):26-31.
10. Kreisberg RA. Diabetic dyslipidemia. Am J Cardiol 1998;82:U67-73.
11. Norhammar A, Malmberg K. Heart failure and glucose abnormalities: an increasing combination with poor functional capacity and outcome. Eur Heart J 2000;21:1293-4.
12. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 1994;343:155-8.
13. Ishihara M, Sato H, Kawagoe T, et al. Impact of diabetes mellitus on long term survival after acute myocardial infarction in patients with single vessel disease. Heart 2001;86:133-8.
14. Van Belle E, Bauters C, Hubert E, et al. Restenosis rates in diabetic patients: a comparison of coronary stenting and balloon angioplasty in native coronary vessels. Circulation 1997;96:1454-60.
15. Ishihara M, Inoue I, Kawagoe T, et al. Diabetes prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol 2001;38:1007-11.
16. Brooks MM, Jones RH, Bach RG, et al. Predictors of mortality and mortality from cardiac causes in the bypass angioplasty revascularization investigation (BARI) randomized trial and registry. For the BARI Investigators. Circulation 2000;101:2682-9.
17. Calafiore AM, Di Mauro M, Di Giammarco G, et al. Effect of diabetes on early and late survival after isolated first coronary bypass surgery in multivessel disease. J Thorac Cardiovasc Surg 2003;125:144-54.
18. Schwartz L, Kip KE, Frye RL, Alderman EL, Schaff HV, Detre KM. Coronary bypass graft patency in patients with diabetes in the Bypass Angioplasty Revascularization Investigation (BARI). Circulation 2002;106:2652-8.
19. Zhao XQ, Brown BG, Stewart DK, et al. Effectiveness of revascularization in the Emory angioplasty vs surgery trial. A randomized comparison of coronary angioplasty with bypass surgery. Circulation 1996;93:1954-62.
20. Detre KM, Lombardero, MS, Brooks MM, et al. The effect of previous coronary-artery bypass surgery on the prognosis of patients with diabetes who have acute myocardial infarction. Bypass Angioplasty Revascularization Investigation Investigators. N Engl J Med 2000;342:989-97.
21. Ortolani P, Ardissino D, Cavallini C, et al. Effect of sirolimus-eluting stent in diabetic patients with small coronary arteries. Am J Cardiol 2005;96:1393-8.
22. Yang TH, Park SW, Hong MK, et al. Impact of diabetes mellitus on angiographic and clinical outcomes in the drug-eluting stents era. Am J Cardiol 2005;96:1389-92.
23. Brandt M, Harder K, Walluscheck KP, et al. Coronary artery bypass surgery in diabetic patients. J Card Surg 2004;19:36-40.
24. Henderson RA, Pocock SJ, Sharp SJ, et al. Long-term results of RITA-1 trial: clinical and cost comparisons of coronary angioplasty and coronary-artery bypass grafting. Randomised Intervention Treatment of Angina. Lancet 1998;352:1419-25.
25. Gum PA, O'Keefe JH Jr, Borkon AM, et al. Bypass surgery vs coronary angioplasty for revascularization of treated diabetic patients. Circulation 1997;96(suppl II):7-10.
26. Niles NW, McGrath PD, Malenka D, et al. Survival of patients with diabetes and multivessel coronary artery disease after surgical or percutaneous coronary revascularization: results of a large regional prospective study. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 2001;37:1008-15.
27. Van Belle E, Perie M, Braune D, et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol 2002;40:410-7.
28. Lincoff AM, Tcheng JE, Califf RM, et al. Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PCI to Improve Long-term Outcome with abciximab GP IIb/ IIIa blockade. Circulation 1999;99:1951-8.